Announcement no. 2/2008
To the OMX Nordic Exchange Copenhagen, January 21,
2008
Financial calendar
Below are the Company's planned dates for financial reporting in 2008:
Year 2007: March 12, 2008
Q1 2008: May 21,2008
Q2 2008: August 27, 2008
Q3 2008: November 19, 2008
The Company's Annual General Meeting is planned for Monday April 21, 2008 in
FUHU Conference centre, Fiolstræde 44, DK-1171 Copenhagen.
Yours sincerely,
Curalogic A/S
For additional information, please contact:
Peter Moldt, President and CEO, Phone +45 99 99 24 00, mobile +45 26 25 04 22
Helle Busck Fensvig, EVP and CFO, Phone +45 99 99 24 00, mobile +45 20 70 55 37
About Curalogic
Curalogic is a Danish biopharmaceutical company listed on the OMX Nordic
Exchange (CUR.CO) as a SmallCap+ company. Curalogic has ample cash resources and
has demonstrated its ability to conduct complex clinical studies with a small
group of development experts.
This announcement contains forward-looking statements regarding the Company's
future financial development and performance and other statements which are not
historical facts. Such statements are made on the basis of assumptions and
expectations which, to the best of the Company's knowledge and belief, are
reasonable, at this time, but may prove to be erroneous in the future.
